cardiovascularTariff appliesAnnex III — Jul 31 2026

Xarelto Tariff Rate & July 31, 2026 Deadline

Xarelto (Rivaroxaban) — manufactured by Johnson & Johnson in Germany. Treats blood thinner (stroke, dvt prevention). Typical US retail $540 per month.

Tariff breakdown

Applicable rate: 100% (Annex III)
Effective date: 2026-07-31 (98 days away)
Manufacturer: Johnson & Johnson
Country of origin: Germany
Annex III?: Yes
Current monthly retail: $540

Projected monthly retail, by pass-through scenario

Scenario	Pass-through	New monthly retail	Annual increase
Conservative	30%	$702	+$1,944
Likely	50%	$810	+$3,240
Worst case	100%	$1,080	+$6,480

Scenarios based on historical brand-pharma cost-shock pass-through. Not a forecast.

HTS classification

HTS 3004.90.9299

Rivaroxaban tablets, retail packaging, HTS 3004.90. Manufactured in Germany by Johnson & Johnson — subject to the 100% tariff.

Source: USITC Harmonized Tariff Schedule, 2026 Revision 2 — hts.usitc.gov

Alternatives: generics, biosimilars & US-made options

Eliquis (apixaban, Bristol-Myers Squibb)

us made

Same DOAC class; BMS produces Eliquis in Puerto Rico — tariff-exempt in practice.

Warfarin (generic)

generic

Legacy vitamin K antagonist, fully genericized, tariff-exempt. Requires INR monitoring.

Rivaroxaban generic (pending)

generic

No FDA-approved US generic as of 2026 Q2. Patent litigation ongoing.

Always consult your prescriber before switching medications. Biosimilars and generics are not interchangeable in every state without physician approval.

FAQ: Xarelto and the 2026 tariff

Will my Xarelto prescription cost more after July 31, 2026?

Likely yes. Xarelto is manufactured in Germany and is not exempt. Our conservative-case scenario assumes 30% pass-through (retail +$162/month), our likely-case 50% (+$270/month), and worst-case full pass-through (+$540/month).

Can I switch to a generic version of Rivaroxaban?

There are generic options listed above — their availability and interchangeability depend on FDA approval and state substitution rules. Confirm with your pharmacist before switching.

Is Xarelto on the Medicare negotiated-price list?

Xarelto is not among the first-round Medicare-negotiated drugs effective 2026. Check CMS announcements for subsequent negotiation rounds.

Importing pharmaceuticals commercially?

This page covers consumer drug pricing. For business imports (including finished-dose pharmaceuticals), use the full US import tariff calculator with HTS classification and Section 301/232/122 breakdown.

Disclaimer: Informational estimates based on public list prices, the April 2, 2026 Proclamation text, and USITC HTS data. Not medical, legal, or financial advice.

Talk to your doctor, pharmacist, and insurer about your specific medication.